Panel: Investor Failed To Plead Strong Inference Of Scienter In Securities Suit
BOSTON — A federal judge did not err in dismissing a securities class action complaint against a pharmaceutical company and certain of its executive officers and directors because a shareholder failed...To view the full article, register now.
Already a subscriber? Click here to view full article